1 – 10 of 26
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
- Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer (
- A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers (
- HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures (
- Societal challenges of precision medicine : Bringing order to chaos (
- Somatic mutations reveal asymmetric cellular dynamics in the early human embryo (
- 2016
- Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer (
- The advantage of laser-capture microdissection over whole tissue analysis in proteomic profiling studies (
- Targeted MS Assay Predicting Tamoxifen Resistance in Estrogen-Receptor-Positive Breast Cancer Tissues and Sera (
- Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer (
- 4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer (